Explore the cutting-edge convergence of psychedelics, business, and policy in our upcoming webinar, co-sponsored by the Hopkins Business of Health Initiative and the Center for Mental Health and Addiction Policy. Delve into the evolving world of psychedelics as a transformative treatment method, understand the burgeoning business landscape surrounding this innovative therapy, and unravel the complex future of policy shaping this field. Join leading experts as they navigate the intricacies of psychedelic treatment, its economic implications, and the policy frontier that will define its role in mental health care. This is a must-attend event for anyone interested in the forefront of mental health treatment and policy innovation.
Panelists
Fred Barrett, PhD, Associate Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine
Melissa Lavasani, Founder and CEO, Psychedelic Medicine Coalition
Lia Mix, LMFT, CEO, Delphi
Co-Moderators:
Matthew Eisenberg, PhD
Associate Professor & Associate Chair for Faculty
Department of Health Policy & Management
Johns Hopkins Bloomberg School of Public Health
Michael Darden, PhD
Associate Professor
Johns Hopkins Carey Business School
Co-Sponsor: Center for Mental Health and Addiction Policy
